Icon

TOPROL-XL (nda019962)- (EQ 50MG TARTRATE,EQ 100MG TARTRATE,EQ 200MG TARTRATE,EQ 25MG TARTRATE)

METOPROLOL SUCCINATE TOPROL
EQ 50MG TARTRATE,EQ 100MG TARTRATE,EQ 200MG TARTRATE,EQ 25MG TARTRATE
Yes No
2011-Mar-21 Expired
None None
None No
TOPROL-XL, metoprolol succinate, is a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. • Angina Pectoris. • Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure
22 0 15
Total Other Developers 14
Drugs with Suitability No
EQ 50MG TARTRATE ** ** Up - 12
EQ 100MG TARTRATE ** ** Down - 12
EQ 200MG TARTRATE ** ** - - 12
EQ 25MG TARTRATE ** ** Down - 11
NDA Sales Available Total Generic Sales Available
Yes 13
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ********* *** ********* (******) **., ***. *********** ******* ********** ****, ****** ****, ****** ********, ****** ****, ********* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ***** ****** ****** *************** ******* *********** ****, ****** ****, ******, *********, ******* ******, ***** (***) ***
****** ****** **** ****** ************ ***. *********** * ********* ****, **** ***** ****, *****, *******, ******* ******, ***** (***) ***
****** ******* ********* **** *************** ***, ***. *********** * ****** ****, *** **, *********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** ***** ***** ***** ************** **., ***. *********** ***-*, ****** ****., ******, ******, ***** (***) ***
****** ***** *** ************ ***. ***. *** *********** ***-***, ****** ******** ****, **** ******,, *****, ******* ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. * &** ****** ******* ******** ****, ***** **, ********* ****, ****** ******* ******, ***** (***) ***
****** ***** ***** ******** ** *** *********** ***** ***** ********* * ******, **-* (** *** **** ***), ****, ********* *****, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***
****** ******* ********* ******* ********* **** ***** ****** ***** *********** **. ***, ******* ****, *******, ***** ******, ***** (***) ***
****** ******** ******** ***** ******* *********** **.**. ***/*, ***/*, ***, ***/*, ********** *******, ********-************* ******, *******-********** ********, ********* ******, ***** (***) ***
****** ****** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ********* *** ********* (******) **., ***. *********** ******* ********** ****, ****** ****, ****** ********, ****** ****, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.